IN8bio, Inc.
INAB
$1.10
-$0.08-6.78%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
8/12/2026
-
TipRanks
8/7/2026
-
TipRanks
8/6/2026
-
TipRanks: TheFly
7/9/2026
-
TipRanks: TheFly
7/9/2026
-
Globe Newswire
6/4/2026
-
Zacks Investment Research
6/3/2026
-
Globe Newswire
5/22/2026
-
TipRanks Financial Blog
5/14/2026
-
Globe Newswire
5/10/2026
-
The Cerbat Gem
5/7/2026
-
Globe Newswire
5/6/2026
-
Globe Newswire
4/6/2026
-
TipRanks Financial Blog
4/3/2026
-
Globe Newswire
3/13/2026
-
TipRanks Financial Blog
3/12/2026
-
Globe Newswire
2/27/2026
-
TipRanks Financial Blog
2/27/2026
-
Ticker Report
2/24/2026
-
Globe Newswire
2/9/2026
-
The Fly
2/9/2026
-
Globe Newswire
2/3/2026
-
Globe Newswire
2/1/2026
-
Ticker Report
1/23/2026
-
TipRanks Financial Blog
Income Statement
Total Revenue (TTM)
--
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, August 6, 2026
Period Date
Tuesday, June 30, 2026
Next Filing
Week of Nov 2 and 6 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
--
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
646 600 6438
Address
350 5th Avenue
Suite 5330
New York, NY 10118
Suite 5330
New York, NY 10118
Country
Year Founded
Business Description
Sector
IN8bio, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of gamma-delta T cell product candidates for the treatment of cancer and...
more